Literature DB >> 18501235

Racial and ethnic variations in hepatocellular carcinoma incidence within the United States.

Robert Wong1, Douglas A Corley.   

Abstract

BACKGROUND: The increasing incidence of hepatocellular carcinoma coupled with this cancer's high mortality is a public health problem. Delineating high-risk populations and cancer patterns can provide valuable information. This is necessary to broaden screening and surveillance guidelines related to early detection and prevention.
METHODS: By using data collected by the Surveillance, Epidemiology, and End Results program, a population-based cancer registry in the United States, our retrospective cohort study evaluated sex-specific, race/ethnicity-specific, and age-specific variations in hepatocellular carcinoma incidence from 1992 to 2004.
RESULTS: With men and women combined, the incidence of hepatocellular carcinoma among Asians was the highest, nearly double that of white Hispanics (11.0 vs 6.8 per 100,000/y), and more than 4 times higher than that of Caucasians (11.0 vs 2.6 per 100,000/y). Although male subjects demonstrated a doubling of cancer rates every 10 years from 30 to 50 years of age, female subjects reached male-comparable rates of cancer 10 to 15 years later and peaked at significantly lower values for all race and ethnic groups.
CONCLUSION: Marked differences in the incidence rates of hepatocellular carcinoma by sex, ethnicity, and age of diagnosis likely represent variations in risk factor distributions (eg, viral hepatitis) and possibly in host genetics or other environmental factors. An individualized approach tailored to specific risk profiles may more effectively identify treatable tumors than more general guidelines.

Entities:  

Mesh:

Year:  2008        PMID: 18501235     DOI: 10.1016/j.amjmed.2008.03.005

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  38 in total

1.  Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions.

Authors:  Kristina A Matkowskyj; Han Bai; Jie Liao; Wanying Zhang; Haonan Li; Sambasiva Rao; Reed Omary; Guang-Yu Yang
Journal:  Hum Pathol       Date:  2013-12-18       Impact factor: 3.466

2.  Liver disease in women: the influence of gender on epidemiology, natural history, and patient outcomes.

Authors:  Jennifer Guy; Marion G Peters
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-10

3.  Analysis of genetic damage and gene polymorphism in hepatocellular carcinoma (HCC) patients in a South Indian population.

Authors:  Subramaniam Mohana Devi; Vellingiri Balachandar; Meyyazhagan Arun; Shanmugam Suresh Kumar; Balasubramanian Balamurali Krishnan; Keshavarao Sasikala
Journal:  Dig Dis Sci       Date:  2012-10-02       Impact factor: 3.199

4.  Heavy alcohol use and premature death from hepatocellular carcinoma in the United States, 1999-2006.

Authors:  Chuanhui Dong; Young-Hee Yoon; Chiung M Chen; Hsiao-Ye Yi
Journal:  J Stud Alcohol Drugs       Date:  2011-11       Impact factor: 2.582

Review 5.  Liver transplantation for hepatocellular carcinoma.

Authors:  M Katherine Rude; Jeffrey S Crippin
Journal:  Curr Gastroenterol Rep       Date:  2015-03

6.  Ethnic and Age Disparities in Outcomes Among Liver Transplant Waitlist Candidates.

Authors:  Margaux N Mustian; Brittany A Shelton; Paul A MacLennan; Rhiannon D Reed; Jared A White; Devin E Eckhoff; Jayme E Locke; Richard M Allman; Stephen H Gray
Journal:  Transplantation       Date:  2019-07       Impact factor: 4.939

Review 7.  Barriers to screening for hepatitis B virus infection in Asian Americans.

Authors:  Ke-Qin Hu; Calvin Q Pan; Diane Goodwin
Journal:  Dig Dis Sci       Date:  2011-08-23       Impact factor: 3.199

8.  Incidence and mortality of primary liver cancer in England and Wales: changing patterns and ethnic variations.

Authors:  Nimzing G Ladep; Shahid A Khan; Mary Me Crossey; Andrew V Thillainayagam; Simon D Taylor-Robinson; Mireille B Toledano
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

9.  Identification of Chromosomal Aberrations by Using Trypsin G-banding in Hepatocellular Carcinoma Patients (HCC) in Tamil Nadu, India.

Authors:  Subramaniam Mohana Devi; Vellingiri Balachandar; Palanivel Vel Murugan; Keshavarao Sasikala; Pappusamy Manikantan; Leela Krishnan Venkatakrishnan
Journal:  Trop Life Sci Res       Date:  2010-08

10.  Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States.

Authors:  Robert J Wong; Douglas A Corley
Journal:  Dig Dis Sci       Date:  2009-01-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.